China State Council’s new directive herald key changes for Chinese R&D

China State Council’s new directive herald key changes for Chinese R&D

In a surprise move, the State Council in China has recently released a directive announcing its view on reforming the drug and medical device review and approval process in China. The State Council oversees the Chinese Food and Drug Administration (CFDA), and it is noteworthy that these changes were announced at a high level, reflecting […]

Read More

September 1st, 2015

CFDA dramatically increase registration fees for drug and clinical trials

China is a highly attractive clinical trial destination, and continues to see increased interest from CROs and drug development companies. China has a well-established tradition of developing medicines from basic research and the demands for modern pharmaceuticals is growing. Data gathered from clinicaltrials.gov indicated that in 2014, China had conducted 846 clinical trials, and an […]

Read More

August 1st, 2015

required
required
required
required
I wish to subscribe to George Clinical communications.
required

Add George Clinical to your network